Literature DB >> 28684247

Inhibition of Cell Division and DNA Replication Impair Mouse-Naïve Pluripotency Exit.

Ariel Waisman1, Camila Vazquez Echegaray1, Claudia Solari1, María Soledad Cosentino1, Iain Martyn2, Alessia Deglincerti2, Mohammad Zeeshan Ozair2, Albert Ruzo2, Lino Barañao3, Santiago Miriuka4, Ali Brivanlou2, Alejandra Guberman5.   

Abstract

The cell cycle has gained attention as a key determinant for cell fate decisions, but the contribution of DNA replication and mitosis in stem cell differentiation has not been extensively studied. To understand if these processes act as "windows of opportunity" for changes in cell identity, we established synchronized cultures of mouse embryonic stem cells as they exit the ground state of pluripotency. We show that initial transcriptional changes in this transition do not require passage through mitosis and that conversion to primed pluripotency is linked to lineage priming in the G1 phase. Importantly, we demonstrate that impairment of DNA replication severely blocks transcriptional switch to primed pluripotency, even in the absence of p53 activity induced by the DNA damage response. Our data suggest an important role for DNA replication during mouse embryonic stem cell differentiation, which could shed light on why pluripotent cells are only receptive to differentiation signals during G1, that is, before the S phase.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DNA replication; cell division; mouse embryonic stem cells introduction; primitive ectoderm-like cells

Mesh:

Year:  2017        PMID: 28684247     DOI: 10.1016/j.jmb.2017.06.020

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

Review 1.  The shifting shape and functional specializations of the cell cycle during lineage development.

Authors:  Yung Hwang; Daniel Hidalgo; Merav Socolovsky
Journal:  WIREs Mech Dis       Date:  2020-09-11

2.  Cell cycle dynamics of mouse embryonic stem cells in the ground state and during transition to formative pluripotency.

Authors:  Ariel Waisman; Federico Sevlever; Martín Elías Costa; María Soledad Cosentino; Santiago G Miriuka; Alejandra C Ventura; Alejandra S Guberman
Journal:  Sci Rep       Date:  2019-05-29       Impact factor: 4.379

3.  Deep Learning Neural Networks Highly Predict Very Early Onset of Pluripotent Stem Cell Differentiation.

Authors:  Ariel Waisman; Alejandro La Greca; Alan M Möbbs; María Agustina Scarafía; Natalia L Santín Velazque; Gabriel Neiman; Lucía N Moro; Carlos Luzzani; Gustavo E Sevlever; Alejandra S Guberman; Santiago G Miriuka
Journal:  Stem Cell Reports       Date:  2019-03-14       Impact factor: 7.765

4.  Dynamical reorganization of the pluripotency transcription factors Oct4 and Sox2 during early differentiation of embryonic stem cells.

Authors:  Paula Verneri; Camila Vazquez Echegaray; Camila Oses; Martin Stortz; Alejandra Guberman; Valeria Levi
Journal:  Sci Rep       Date:  2020-03-23       Impact factor: 4.379

5.  Novel Interplay between p53 and HO-1 in Embryonic Stem Cells.

Authors:  Ayelén Toro; Nicolás Anselmino; Claudia Solari; Marcos Francia; Camila Oses; Pablo Sanchis; Juan Bizzotto; Camila Vazquez Echegaray; María Victoria Petrone; Valeria Levi; Elba Vazquez; Alejandra Guberman
Journal:  Cells       Date:  2020-12-29       Impact factor: 6.600

6.  Single cell transfection of human-induced pluripotent stem cells using a droplet-based microfluidic system.

Authors:  Camilo Pérez-Sosa; Anahí Sanluis-Verdes; Ariel Waisman; Antonella Lombardi; Gustavo Rosero; Alejandro La Greca; Shekhar Bhansali; Natalia Bourguignon; Carlos Luzzani; Maximiliano S Pérez; Santiago Miriuka; Betiana Lerner
Journal:  R Soc Open Sci       Date:  2022-01-12       Impact factor: 2.963

7.  Abscission Couples Cell Division to Embryonic Stem Cell Fate.

Authors:  Agathe Chaigne; Céline Labouesse; Ian J White; Meghan Agnew; Edouard Hannezo; Kevin J Chalut; Ewa K Paluch
Journal:  Dev Cell       Date:  2020-09-25       Impact factor: 12.270

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.